Banerjee A - Search Results

1

Pathways to care for Long COVID and for long-term conditions from patients' and clinicians' perspective.

Turk F, Sweetman J, Allsopp G, Crooks M, Cuthbertson DJ, Gabbay M, Hishmeh L, Lip GYH, Strain WD, Williams N, Wootton D, Banerjee A, van der Feltz-Cornelis C; STIMULATE-ICP Consortium. Turk F, et al. Among authors: banerjee a. J Evid Based Med. 2023 Dec;16(4):435-437. doi: 10.1111/jebm.12563. Epub 2023 Nov 30. J Evid Based Med. 2023. PMID: 38037477 Free article. No abstract available.

2

Bleeding risk with oral anticoagulation--new frontiers and new questions.

Banerjee A, Lane DA, Lip GY. Banerjee A, et al. Int J Clin Pract. 2011 Jul;65(7):719-21. doi: 10.1111/j.1742-1241.2011.02716.x. Int J Clin Pract. 2011. PMID: 21676114 No abstract available.

3

The improved but unfinished business of stroke risk stratification in atrial fibrillation.

Banerjee A, Marín F, Lip GY. Banerjee A, et al. Rev Esp Cardiol. 2011 Aug;64(8):639-41. doi: 10.1016/j.recesp.2011.04.005. Epub 2011 Jun 17. Rev Esp Cardiol. 2011. PMID: 21684058 Free article. English, Spanish. No abstract available.

4

Intracerebral hemorrhage and warfarin: perceived versus actual risk.

Banerjee A, Lip GY. Banerjee A, et al. Stroke. 2011 Sep;42(9):2383-4. doi: 10.1161/STROKEAHA.111.626739. Epub 2011 Jul 28. Stroke. 2011. PMID: 21799157 No abstract available.

5

Improving the diagnosis and prognosis of atrial fibrillation in stroke: quo vadis?

Banerjee A, Lip GY. Banerjee A, et al. Eur J Neurol. 2012 Feb;19(2):187-8. doi: 10.1111/j.1468-1331.2011.03516.x. Epub 2011 Sep 14. Eur J Neurol. 2012. PMID: 21914055 No abstract available.

6

Looking through the PRISM: new insights for young patients with atrial fibrillation and stroke.

Banerjee A, Lip GY. Banerjee A, et al. Cerebrovasc Dis. 2011;32(4):383-4. doi: 10.1159/000331464. Epub 2011 Sep 15. Cerebrovasc Dis. 2011. PMID: 21921602 Free article. No abstract available.

7

A new landscape for stroke prevention in atrial fibrillation: focus on new anticoagulants, antiarrhythmic drugs, and devices.

Banerjee A, Marín F, Lip GY. Banerjee A, et al. Stroke. 2011 Nov;42(11):3316-22. doi: 10.1161/STROKEAHA.111.617886. Epub 2011 Oct 13. Stroke. 2011. PMID: 21998051 Review.

8

Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study.

Banerjee A, Lane DA, Torp-Pedersen C, Lip GY. Banerjee A, et al. Thromb Haemost. 2012 Mar;107(3):584-9. doi: 10.1160/TH11-11-0784. Epub 2011 Dec 21. Thromb Haemost. 2012. PMID: 22186961

9

Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project.

Banerjee A, Taillandier S, Olesen JB, Lane DA, Lallemand B, Lip GY, Fauchier L. Banerjee A, et al. Eur J Heart Fail. 2012 Mar;14(3):295-301. doi: 10.1093/eurjhf/hfs005. Epub 2012 Jan 30. Eur J Heart Fail. 2012. PMID: 22294759 Free article.

10

Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project.

Banerjee A, Taillandier S, Olesen JB, Lane DA, Lallemand B, Lip GY, Fauchier L. Banerjee A, et al. Int J Cardiol. 2013 Sep 10;167(6):2682-7. doi: 10.1016/j.ijcard.2012.06.118. Epub 2012 Jul 15. Int J Cardiol. 2013. PMID: 22795403

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,082 results

Search Page

Filters